Pictet North America Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,864
| Closed | -$300K | – | 131 |
|
|
2023
Q1 | $300K | Sell |
33,864
-45,825
| -58% | -$406K | 0.05% | 109 |
|
|
2022
Q4 | $727K | Sell |
79,689
-845,718
| -91% | -$7.71M | 0.13% | 83 |
|
|
2022
Q3 | $7.47M | Sell |
925,407
-5,825
| -0.6% | -$47K | 1.19% | 26 |
|
|
2022
Q2 | $7M | Sell |
931,232
-33,678
| -3% | -$253K | 0.93% | 29 |
|
|
2022
Q1 | $9.06M | Sell |
964,910
-8,218
| -0.8% | -$77.2K | 1.05% | 27 |
|
|
2021
Q4 | $7.8M | Sell |
973,128
-7,077
| -0.7% | -$56.7K | 0.77% | 31 |
|
|
2021
Q3 | $9.55M | Sell |
980,205
-6,957
| -0.7% | -$67.8K | 0.94% | 30 |
|
|
2021
Q2 | $9.83M | Buy |
987,162
+12,693
| +1% | +$126K | 1.02% | 27 |
|
|
2021
Q1 | $11.1M | Buy |
974,469
+875,006
| +880% | +$9.97M | 1.3% | 25 |
|
|
2020
Q4 | $946K | Buy |
99,463
+39,768
| +67% | +$378K | 0.12% | 78 |
|
|
2020
Q3 | $541K | Sell |
59,695
-6,750
| -10% | -$61.2K | 0.08% | 98 |
|
|
2020
Q2 | $800K | Hold |
66,445
| – | – | 0.11% | 85 |
|
|
2020
Q1 | $612K | Buy |
+66,445
| New | +$612K | 0.1% | 93 |
|
|
2019
Q2 | – | Sell |
-60,994
| Closed | -$950K | – | 157 |
|
|
2019
Q1 | $950K | Sell |
60,994
-2,651
| -4% | -$41.3K | 0.14% | 83 |
|
|
2018
Q4 | $999K | Sell |
63,645
-46,232
| -42% | -$726K | 0.09% | 77 |
|
|
2018
Q3 | $2.41M | Buy |
109,877
+4,049
| +4% | +$88.8K | 0.32% | 50 |
|
|
2018
Q2 | $2.51M | Buy |
105,828
+12,338
| +13% | +$293K | 0.37% | 48 |
|
|
2018
Q1 | $1.59M | Buy |
+93,490
| New | +$1.59M | 0.24% | 63 |
|
|
2017
Q4 | – | Sell |
-105,149
| Closed | -$1.84M | – | 137 |
|
|
2017
Q3 | $1.84M | Buy |
+105,149
| New | +$1.84M | 0.29% | 60 |
|
|
2017
Q2 | – | Sell |
-471,083
| Closed | -$15.5M | – | 138 |
|
|
2017
Q1 | $15.5M | Buy |
+471,083
| New | +$15.5M | 2.58% | 14 |
|